Émilie ROYERE
MBA
-
General Director of the competitiveness cluster Eurobiomed
Eurobiomed
This is the DNA of the cluster to feed local excellence, including, of course, fundamental and applied immunology, and to support the emergence of sector initiatives with strong potential.
I participated in 2004 in the creation of the Bioméditerranée cluster foreshadowing the Eurobiomed competitiveness cluster, which is currently the catalyst of the health sector in the Provence-Alpes-Côte d’Azur and Languedoc-Roussillon regions with 400 companies, 8 Universities, 400 research centres, 4 University Hospitals Centres and one Interregional Clinical Research Organization.
This is the DNA of the cluster to feed local excellence, including, of course, fundamental and applied immunology, and to support the emergence of sector initiatives with strong potential. Marseille Immunopole is a perfect illustration of this approach and we are very proud of the magnitude taken today by this new operation initiated in 2013. Eurobiomed still remains very involved, animating the community and participating in the driving force that allows the creation of start-ups and the development of industrials and service companies in MI and the implementation of ambitious partnerships in France and internationally on these issues.
#ecosystèmeHave a look on our testimonies
For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .
Nicolas SCHLEINITZ
AP-HM, AMU
With MI-mAbs and other cluster platforms, CIPHE is somewhat the "technology back office" of Marseille Immunopole.
Bernard MALISSEN
CIPHE, CIML
The thrust of MI is the ability of Marseille researchers, clinicians and industrials to play as a team.
Hervé BRAILLY
Innate Pharma
HalioDx is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.
Vincent FERT
HALIODX
your commitment to MI